Rachel Swansburg 5/27/25 Rachel Swansburg 5/27/25

Biogen taps City Therapeutics in RNAi deal worth up to $1B

Read More

Rachel Swansburg 2/11/25 Rachel Swansburg 2/11/25

John Maraganore shares his take on biotech in 2025 and discusses the science behind his recently launched RNAi company, City Therapeutics

Read More

Rachel Swansburg 1/10/25 Rachel Swansburg 1/10/25

Bausch + Lomb pens $485M-plus biobucks pact with City Tx for RNAi eye disease work

Read More

Rachel Swansburg 10/10/24 Rachel Swansburg 10/10/24

Crypto for CRISPR, a new RNAi startup, & a Nobel for AI

Read More

Rachel Swansburg 10/8/24 Rachel Swansburg 10/8/24

Startup led by John Maraganore raises $135M to build ‘future of RNAi’

Read More

Rachel Swansburg 10/8/24 Rachel Swansburg 10/8/24

City Therapeutics breaks ground with $135M and blueprints from RNAi expert John Maraganore

Read More

Matthew Zola 10/8/24 Matthew Zola 10/8/24

Biotech veteran John Maraganore raises $135 million for his ‘next-generation RNAi’ startup

Read More